Phenytoin Articles
Patent cliff: one drugmaker's sorrow is another one's joy
20 January 2013
India: price-controlled drugs see sales rise
16 October 2006
Second FDA drug imports "blitz" finds 80% come from Canada
9 February 2004
Pakistan drug supply situation eased
20 February 2001
Florida moves on five neg formulary drugs
26 January 2001
W-A's Premarin is top US formulary drug
29 November 2000
FDA approves Dilantin Kapseals generic
30 December 1998
Epilepsy Market Sees Strong Growth
29 July 1997
Health Insurers In Massachusetts To Pay For AIDS Drugs
22 April 1996
Higher-Priced Drugs Set To Expand Epilepsy Market
12 February 1996
Warner-Lambert: Value As Acquisition?
4 December 1995
Warner-Lambert Fined Over Epilepsy Drug
4 December 1995
FDA Committee Gives Nod To Glaxo's OTC Zantac
24 July 1995
Encouraging Results With Tiagabine
9 January 1995
Monotherapy Filing For Lamotrigine In UK
26 September 1994
FDA YEAR-END APPROVALS FOR 1993
10 January 1994
WARNER-LAMBERT CONSENT AGREEMENT
23 August 1993
NEW HOPES FOR EPILEPSY TREATMENT
12 July 1993
WARNER-LAMBERT ALZA agreement
10 May 1993
WORLD CNS MARKET IS LARGE AND FRAGMENTED
22 February 1993
RECORD RESULTS FROM US PHARMA MAJORS
1 February 1993
US GAO REPORT SLAMS DRUG PRICES
7 September 1992
WARNER-LAMBERT EARNINGS FORECAST
29 June 1992
NEW DRUGS FOR EPILEPTICS
13 January 1992
Showing 1-28 of 28 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
